Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-08

FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for NOVOLIN R (human insulin) submitted by Novo Nordisk. The action represents regulatory approval for changes under…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOVOLIN R (HUMAN INSULIN)

Snippet

SUPPL AP for NOVOLIN R (HUMAN INSULIN)